¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"organ specific"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • embryonic organ
    ¹è¾Æ±â°ü
  • enamel organ
    ¿¡³ª¸á±â°ü
  • end organ
    Á¾¸»±â°ü
  • end organ deafness
    Á¾¸»±â°ü³­Ã»
  • endocrine organ
    ³»ºÐºñ±â°ü
  • female genital organ
    ¿©¼º»ý½Ä±â°ü
  • genital organ
    »ý½Ä±â°ü
  • Golgi tendon organ
    °ñÁöÈûÁÙ±â°ü
  • gustatory organ
    ¹Ì°¢±â°ü
  • hemopoietic organ
    Á¶Ç÷±â°ü, Ç÷±¸Çü¼º±â°ü
  • holdfast organ
    ÈíÂø±â°ü
  • insectivorous organ
    ½ÄÃæ±â°ü
  • leukopoietic organ
    ¹éÇ÷±¸Çü¼º±â°ü
  • male genital organ
    ³²¼º»ý½Ä±â°ü
  • motor end organ
    ¿îµ¿Á¾¸»±â°ü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • organ donor
    Àå±âÁ¦°øÀÚ, Àå±âÁÖ´ÂÀÌ
  • organ tolerance dose
    ±â°ü°ßµõ¼±·®
  • effector organ
    È¿°ú±â, È¿°ú±â°ü
  • embryonic organ
    ¹è¾Æ±â°ü
  • enamel organ
    »ç±âÁú±â°ü
  • end organ
    Á¾¸»±â°ü
  • endocrine organ
    ³»ºÐºñ±â°ü
  • excretory organ
    ¹è¼³±â°ü
  • external genital organ
    ¹Ù±ù»ý½Ä±â°ü
  • extraperitoneal organ
    º¹¸·¹Ù±ù±â°ü, ¹è¸·¹Ù±ù±â°ü
  • female genital organ
    ¿©¼º»ý½Ä±â°ü
  • genital organ
    »ý½Ä±â°ü
  • Golgi tendon organ
    °ñÁöÈûÁÙ±â°ü
  • gustatory organ
    ¹Ì°¢±â°ü
  • hemopoietic organ
    Ç÷¾×Çü¼º±â°ü, Á¶Ç÷±â°ü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • specific disease
    ƯÀÌÁúȯ(¡­òðü´)
  • specific dispersion
    ºñºÐ»ê(ÝïÝÂߤ).
  • specific electric conductivity
    ºñÀü±âÀüµµÀ²(Ýïï³Ñ¨îîÓôëÒ).
  • specific energy of sense
    Ư¼ö°¨°¢¿¡³ÊÁö.
  • specific fertility rate
    ƯÁ¤Ãâ»êÀ²(Ì¬Ëø ̧Ë×Ëô).
  • specific gamma emission
    Ư¼º°¨¸¶¼±¹æÃâ
  • specific gas constant
    ºñ±âü»ó¼ö(ÝïѨô÷ ßÈâ¦).
  • specific granule
    ƯÀ̰ú¸³
  • specific granules
    Ư¼ö°ú¸³(÷åâ¨Î¨Ø£)
  • specific gravity
    ºñÁß(Ýïñì).
  • specific gravity test
    ºñÁß½ÃÇè(ÝïñìãËúÐ).
  • specific growth rate
    ƯÁ¤Áõ½ÄÀ²
  • specific heat
    ºñ¿­(Ýïæð).
  • specific humidity
    ºñ½Àµµ.
  • specific inflammation
    ƯÀ̼º¿°(¡­àõæú)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
MSOF multiple systems organ failure
OAR organ at risk
OBF organ blood flow
OC obstetrical conjugate; occlusocervical; office call; on call; only child; optic chiasma; oral contra...
OPO Organ Procurement Organization
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
SFO Subfornical Organ
TOD Target organ damage
UNOS United Network for Organ Sharing
UNOS United Network of Organ Sharing
VNO vomeronasal organ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • sensory organ
    °¨°¢±â
    ¸öÀÇ ¿ÜºÎ ¹× ³»ºÎ¿¡¼­ Àü´ÞµÇ´Â ÀÚ±ØÀ» ¼ö¿ëÇϰí ÈïºÐÇÏ¿© ±×°ÍÀ» ÁßÃß ½Å°æÀ¸·Î Àü´ÞÇÏ´Â ±â°ü. ÀϹÝÀûÀ¸·Î ´Ù¼öÀÇ ¼ö¿ë±â°¡ ÁýÇÕÇÏ¿© ÀÌ·ç¾îÁø´Ù. »ý¸®Çп¡¼­´Â °¨°¢±â¿Í °°Àº ¶æÀ¸·Î ¼ö¿ë±â¶ó°íµµ ÇÑ´Ù. ±×·¯³ª ¼ö¿ë±â¶ó´Â ¸»Àº °¨°¢±â ¾È¿¡¼­ Á÷Á¢ ÀÚ±ØÀ» ¼ö¿ëÇϰí, ÈïºÐÀÌ µÇ´Â ¼¼Æ÷¸¦ ¶æÇÏ´Â °æ¿ì°¡ ¸¹´Ù. µ¿¹°Àº ¿Ü°èÀÇ ¿©·¯ Àڱؿ¡ µû¶ó ¹ÝÀÀÇÑ´Ù. ¹ÝÀÀÀ̶ó´Â °ÍÀº ¹Ý»ç¶ó°í ÇÏ´Â ÀǽĿ¡µµ ¹ÌÄ¡Áö ¸øÇÏ´Â ±ØÈ÷ °íÁ¤ÀûÀÎ ¿îµ¿ÀÏ °æ¿ìµµ ÀÖ°í, Á¾¿¡ µû¶ó º¹ÀâÇÑ À̸¥¹Ù º»´ÉÇൿÀ̶ó´Â °ÍÀÏ ¼öµµ ÀÖÀ¸¸ç, ¿ì¸®°¡ üÇèÇÏ´Â °Í °°Àº Áö°¢»óÀÇ °¨°¢À» ÀÏÀ¸Å°°Ô ÇÏ´Â °ÍÀÏ ¼öµµ ÀÖ´Ù. ½ÇÁ¦·Î ù ´Ü°è·Î¼­ ¿Ü°èÀÇ Æ¯¼öÇÑ ÀÚ±ØÀÌ ¼ö¿ëµÇ¾î ¼ö¿ë±â ¼¼Æ÷¿¡ ÈïºÐÀ» ÀÏÀ¸Å°°í, ±× °á°ú·Î¼­ ±×°Í¿¡ Á¢¼ÓµÈ °¨°¢¼º ½Å°æ ¼¶À¯¿¡ ÀÓÆÞ½º
  • sexual organ
    »ý½Ä±â, »ý½Ä ±â°ü
    »ý½Ä±â°¡ genital organÀÇ Á÷¿ªÀε¥ ´ëÇØ ¼º±â´Â sexual organÀÇ Á÷¿ªÀÌ´Ù. ÀϹÝÀûÀ¸·Î´Â »ç¶÷ÀÇ »ý½Ä ±â°üÀ» °¡¸®ÄÑ ¸»ÇÏ´Â °æ¿ì°¡ ¸¹°í, ³²³à¿¡ µû¶ó ±× ±¸Á¶°¡ ÇöÀúÇÏ°Ô ´Ù¸£´Ù. »ç¶÷ÀÇ ¼º±â´Â ¹ß»ýÇÐÀûÀ¸·Î ¿Ü¼º±â¿Í ³»¼º±â·Î ±¸º°µÇ°í, ÀüÀÚ´Â ¿ÜºÎ¿¡ ³ªÅ¸³ª´Â ¼º±â·Î ÁÖ·Î ±³Á¢±â°¡ µÇ¸ç ÈÄÀÚ´Â »ý½Ä ±â´ÉÀ» °®´Â ±â°üÀÌ´Ù.
  • solid organ
    ½ÇÁú ±â°ü, ½ÇÁú Àå±â
  • sound organ
    ¹ßÀ½±â
  • sound-producting organ
    ¹ßÀ½ ±â°ü
  • target organ
    Ç¥Àû ±â°ü
    È£¸£¸óÀÌ ±× Ư¼º¿¡ µû¶ó ¾î¶² ÀÏÁ¤ÇÑ Á¶Á÷À̳ª ±â°ü¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¶§ À̵é Á¶Á÷À̳ª ±â°üÀ» Ç¥Àû ±â°üÀ̶ó ÇÑ´Ù.
  • taste organ
    ¹Ì°¢ ±â°ü, ¹Ì°¢±â
    ¸ÀÀ» °¨°¢ÇÒ ¼ö ÀÖ´Â ±â°ü.
  • total organ duplication
    Àüü ±â°ü Áߺ¹
  • unit organ duplication
    ±â°ü Áߺ¹
  • urogenital organ
    ºñ´¢ »ý½Ä ±â°ü
    ȸÀ½ºÎ¸¦ ±¸¼ºÇÏ´Â ±â°ü.
  • vegatative organ
    ¿µ¾ç ±â°ü
  • visceral organ
    ³»Àå ±â°ü
  • visual organ
    ½Ã°¢±â
  • vital organ
    »ý¸í À¯Áö ±â°ü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
Gomori's non-specific alkaline phosphatase stain <technique> A calcium-cobalt sulfide method using frozen sections or cold acetone-or formalin-fixed paraffin sections, plus sodium beta-glycerophosphate as a substrate at pH 9.0 to 9.5 with Mg++ as activator; calcium ions precipitate the liberated phosphate, cobalt salt replaces the calcium phosphate, and ammonium sulfide converts the product to a black cobalt sulfide.
(05 Mar 2000)
group-specific protease <enzyme> A serine protease, obtained from rat small intestine, which preferentially inactivates the apo forms of certain pyridoxal phosphate requiring enzymes
Registry number: EC 3.4.21.-
(26 Jun 1999)
RNA, transfer, amino acid-specific A group of transfer rnas which are specific for carrying each one of the 20 amino acids to the ribosome in preparation for protein synthesis.
(12 Dec 1998)
poly A specific exoribonuclease <enzyme> Acts on 2' or 3'-linked oligoriboadenylates to liberate 5'-AMP
Registry number: EC 3.1.13.-
Synonym: 2',3'-exoribonuclease, 3'-exoribonuclease
(26 Jun 1999)
poly(A)-specific ribonuclease <enzyme> From vigna unguiculata seedlings; bifunctional enzyme responsible for both poly(a)-polymerizing and poly(a)-hydrolyzing activities; removes the poly(a) tail as the first step in degrading mRNA
Registry number: EC 3.1.13.4
Synonym: poly(a) nuclease, mRNA poly(a) nuclease, poly(a) ribonuclease (pan), pan2 protein
(26 Jun 1999)
myelencephalon-specific serine protease <enzyme> Specifically expressed in the nervous system; plays a role in normal homeostasis and response of spinal cord to injury.
Registry number: EC 3.4.21.-
Synonym: myelencephalon-specific protease, msp enzyme
(26 Jun 1999)
pregnancy-specific beta 1-glycoprotein A glycoprotein with the electrophoretic mobility of a beta-1 globulin. It is produced by the placental trophoblast and secreted into the maternal bloodstream during pregnancy. It can be detected 18 days after ovulation and its concentration in plasma rises steadily until, at the end of gestation, it reaches 200 mg/ml. It has been proposed as a measure of placental function for fertility control and is a candidate for an early pregnancy test.
(12 Dec 1998)
prenylated peptide-specific endoprotease <enzyme> Cleaves c-terminal tripeptide from prenylated protein having c-terminal sequence caax; race is rac and a-factor converting enzyme with same activity
Registry number: EC 3.4.14.-
Synonym: prenylated protein endoprotease, race enzyme, isoprenylated protein endopeptidase, isoprenylated protein endoprotease
(26 Jun 1999)
cytosol non-specific dipeptidase <enzyme> Also referred to as peptidase a (see synonym to penicillopepsin, EC 3.4.23.20)
Registry number: EC 3.4.13.-
Synonym: glycyl-l-leucine hydrolase, glycylleucine dipeptidase, gly-leu dipeptide peptidase, dipeptide hydrolase, glycyl-leucine dipeptidase
(26 Jun 1999)
cytotoxic T lymphocyte-specific serine protease <enzyme> Structural sequence given in first source
Registry number: EC 3.4.21.-
Synonym: cytotoxic t lymphocyte-specific serine protease ccp I, cytotoxic t lymphocyte specific serine protease ccp II, mast cell protease type II
(26 Jun 1999)
proline-specific dipeptidylcarboxypeptidase <enzyme> From streptomyces species; removes diproline form c-terminus of proline-containing peptides such as boc-pro-pro-pro-pro or leu-pro-pro-pro-pro-pro
Registry number: EC 3.4.15.-
Synonym: pro-dpp-carboxypeptidase
(26 Jun 1999)
prostate-specific antigen <tumour marker> A simple blood test used to detect prostate cancer in men. The test measures a specific antigen normally secreted by the prostate. If cancer is developing, the prostate secretes greater amounts of prostate-specific antigen. This test is recommended for men with an enlarged prostate and an increased risk of prostate cancer.
It is an enzyme that is produced by epithelial cells of both benign and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer.
It is a single chain 31 kilodalton glycoprotein with 240 amino acid residues and 4 carbohydrate side chains that is a kallikrein protease.
It is found in normal seminal fluid and produced by the prostatic epithelial cells.
Elevated levels in blood serum are associated with prostatic enlargement and prostatic adenocarcinoma, and this allows early detection of cancer in many cases. In about 70% of cases, the rise is due to a cancerous condition.
No large scale clinical studies have been completed to assess the impact of testing on survival from prostate cancer, and the medical and economic value of testing remain uncertain.
Acronym: PSA
Registry number: EC 3.4.21.77
(22 Sep 2002)
pyrimidine-guanine sequence-specific ribonuclease <enzyme> From yolk granules of adult rana catesbeiana oocytes
Registry number: EC 3.1.27.-
Synonym: rc-rnase, rana catesbeiana rnase
(26 Jun 1999)
site-specific mutagenesis <cell culture, molecular biology> An in vitro technique in which an alteration is made at a specific site in a DNA molecule, which is then reintroduced into a cell. Various techniques are used, for the cell biologist, a very powerful approach to determining which parts of a protein or nucleotide sequence are critical to function.
(18 Nov 1997)
site specific mutation An alteration of the structure of a gene at a specific sequence, usually referring to experimentally produced changes in gene sequence.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á